Skip to main content
SpringerLink
Log in

Hormones by administration

  • Chapter
The Treatment of Breast Cancer

Abstract

The hormone dependence of human breast cancer was discovered at the turn of the century by Beatsonl who reported beneficial effects from oöphorectomy as a treatment of this disease. The clinical value of ovarian ablation was fully confirmed during subsequent years, and both radiation and surgical castration became established therapeutic procedures in operable or generalised breast cancer2,3.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beatson, G. T. (1896). On the treatment of inoperable cases of carcinoma of the mamma. Suggestion for a new method of treatment with illustrative cases. Lancet, ii, 104

    Google Scholar 

  2. Adair, F. E., Treves, N., Farrow, J. H. and Scharnagel, I. M. (1945). Clinical effects of surgical and X-ray castration in mammary cancer. 3. Amer. Med. Ass., 128, 161

    Google Scholar 

  3. Ahlbom, H. (1930). Castration by roentgen rays as an auxiliary treatment in the radiotherapy of cancer mammae at Radiumhemmet, Stockholm. Acta Radio!. (They.) (Stockholm), 11, 614

    Google Scholar 

  4. Lacassagne, A. (1938). Apparition d’adénocarcinomes mammaires chez des souris mâles traitées par une substance oestrogène synthétique. C.R. Soc. Biot. (Paris), 129, 641

    CAS  Google Scholar 

  5. Lacassagne, A. and Raynaud, A. (1939). Sur le mécanisme d’une action préventive de la testostérone sur le cancer mammaire de la souris. C.R. Soc. Biol. (Paris), 131, 586

    CAS  Google Scholar 

  6. Nathanson, I. T. and Andervont, H. B. (1939). Effect of testosterone propionate on development and growth of mammary carcinoma in female mice. Proc. Soc. Exp. Biol. Med., 40, 421

    CAS  Google Scholar 

  7. Badger, G. M., Elson, L. A., Haddow, A., Hewett, C. L. and Robinson, A. M. (1942). The inhibition of growth by chemical compounds. Proc. Roy. Soc. Lond. (Biol.), 130, 255

    CAS  Google Scholar 

  8. Loeser, A. (1939). Male hormone in the treatment of cancer of the breast. Acta Unio. Int. Contra. Cancro., 4, 375

    Google Scholar 

  9. Ulrich, P. (1939). Testostérone (hormone mâle) et son rôle possible dans le traitement de certains cancers du sein. Acta Unio. Int. Contra. Cancro., 4, 377

    Google Scholar 

  10. Ellis, F. and others (1944). Stilboestrol for advanced breast cancer. Brit. Med. J., ii, 20

    Google Scholar 

  11. Ellis, F. and others (1944). Discussion on advanced cases of carcinoma of the breast treated by stilboestrol. Proc. Roy. Soc. Med., 37, 731

    Google Scholar 

  12. Haddow, A., Watkinson, J. M., Paterson, E. and Koller, P. C. (1944). Influence of synthetic oestrogen upon advanced malignant disease. Brit. Med. J., it 393

    Google Scholar 

  13. Haddow, A., Watkinson, J. M., Paterson, E. and Koller, P. C. (1944). Influence of synthetic oestrogen upon advanced malignant disease. Brit. Med. J., it 393

    Google Scholar 

  14. Cooperative Breast Cancer Group (1964). Testosterone propionate therapy in breast cancer. J. Amer. Med. Ass., 188, 1069

    Google Scholar 

  15. Council on Drugs (1960). Androgens and estrogens in the treatment of disseminated mammary carcinoma. Retrospective study of nine hundred forty-four patients. Report to the Council. J`. Amer. Med. Ass., 172, 1271

    Google Scholar 

  16. Kennedy, B. J. and Nathanson, I. T. (1953). Effects of intensive sex steroid hormone therapy in advanced breast cancer, report to the Council on Pharmacy and Chemistry. y. Amer. Med. Ass., 152, 1135

    Google Scholar 

  17. Taylor, S. G. III, Slaughter, D. P., Smejkal, W., Fowler, E. F. and Preston, F. W. (1948). The effect of sex hormones on advanced carcinoma of breast. Cancer, 1, 604

    Google Scholar 

  18. Kofman, S., Garvin, J. S., Nagamani, D. and Taylor, S. G. III (1957). Treatment of cerebral metastases from breast carcinoma with prednisolone. y. Amer. Med. Ass., 163, 1473

    CAS  Google Scholar 

  19. Cole, M. P., Jones, C. T. A. and Todd, I. D. H. (1971). A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI 46474. Brit. J. Cancer, 25, 270

    PubMed  CAS  Google Scholar 

  20. E.O.R.T.C. Breast Cancer Group (1972). Clinical trial of Nafoxidine, an oestrogen antagonist in advanced breast cancer. Eur. J. Cancer, 8, 387

    Google Scholar 

  21. E.O.R.T.C. Breast Cancer Group (1972). Clinical trial of 2-Br-a-ergocryptine (CB 154) in advanced breast cancer. Eur.,7. Cancer, 8, 155

    Google Scholar 

  22. E.O.R.T.C. Breast Cancer Group (1972). Clinical trial of the cyclic imide 1-(morpholinomethyl)-4-phtalimido-piperidindione-2,6 (CG 603) in advanced breast cancer. Eur. J. Cancer, 8, 157

    Google Scholar 

  23. Murray, R. H. L., Mozzaffarian, G. and Pearson, O. H. (1972). Prolactin levels with L-dopa treatment in metastatic breast carcinoma. Prolactin and Carcinogenesis. Proceedings of the Fourth Tenovus Workshop, p. 158, ( Edited by A. R. Boyns and K. Griffiths). Alpha Omega Alpha Publishing, Cardiff

    Google Scholar 

  24. Prudente, A. (1945). Postoperative prophylaxis of recurrent mammary cancer with testosterone propionate. Surg. Gyncol. Obstet., 80, 575

    Google Scholar 

  25. Cooperative Breast Cancer Group: Progress report (1961). Results of studies by the Cooperative Breast Cancer Group, 1956-1960. Cancer Chemother. Rep., 11, 109

    Google Scholar 

  26. G.E.C.A. (1967). Protocole pour les essais cliniques de traitement des cancers mammaires humains en phase avancée. Eur. J. Cancer, 2, 201

    Google Scholar 

  27. Haddow, A. (1935). Influence of certain polycyclic hydrocarbons on the growth of the Jensen rat sarcoma. Nature (Lond.), 136, 868

    CAS  Google Scholar 

  28. Cook, J. W., Dodds, E. C., Hewett, C. L. and Lawson, W. (1934). Oestrogenic activity of some condensed-ring compounds in relation to their other biological activities. Proc. Roy. Soc. Lond. (Biol.), 114, 272

    CAS  Google Scholar 

  29. Haddow, A. and Robinson, A. M. (1937). Influence of various polycyclic hydrocarbons on growth rate of transplantable tumours. Proc. Roy. Soc. Load. (Biol.), 122, 442

    CAS  Google Scholar 

  30. Noble, R. L. (1939). Effects of continuous oral administration of aqueous diéthylstilboestrol solutions to rats. j. Endocrinol., 1, 128

    CAS  Google Scholar 

  31. Zondek, B. (1936). Impairment of anterior pituitary functions by follicular hormone. Lancet, ii, 842

    Google Scholar 

  32. Gardner, W. U. and De Vita, J. (1940). Malignant and non-malignant uterine and vaginal lesions in mice receiving estrogens, and estrogens and androgens simultaneously. Yale J. Biol. Med., 13, 213

    PubMed  CAS  Google Scholar 

  33. Hooker, C. W., Gardner, W. U. and Pfeiffer, C. A. (1940). Testicular tumors in mice receiving estrogens. J. Amer. Med. Ass., 115, 443

    CAS  Google Scholar 

  34. Gardner, W. U. (1941). Inhibition of mammary growth by large amounts of estrogen. Endocrinology, 28, 53

    CAS  Google Scholar 

  35. Huggins, C. and Hodges, C. V. (1941). Studies of prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1, 292

    Google Scholar 

  36. Biden, W. M. (1943). Stilboestrol for breast tumour. Brit. Med. y., ii, 57

    Google Scholar 

  37. Nathanson, I. T. (1952). Clinical investigative experience with steroid hormones in breast cancer. Cancer, 5, 754

    PubMed  CAS  Google Scholar 

  38. Nathanson, I. T. and Kelley, R. M. (1952). Hormonal treatment of cancer. X. Engl. J. Med., 246, 135

    CAS  Google Scholar 

  39. Stoll, B. A. (1950). Hormone therapy in relation to radiotherapy in the treatment of advanced carcinoma of the breast. Proc. Roy. Soc. Med., 43, 875

    PubMed  CAS  Google Scholar 

  40. Pearson, O. H., West, C. D., Hollander, V. P. and Treves, N. E. (1954). Evaluation of endocrine therapy for advanced breast cancer. J. Amer. Med. Ass., 154, 234

    Google Scholar 

  41. Kennedy, B. J. (1962). Massive estrogen administration in premenopausal women with metastatic breast cancer. Cancer, 15, 641

    PubMed  CAS  Google Scholar 

  42. Nemoto, T. and Dao, T. L. (1966). Significance of liver metastases in women with disseminated breast cancer undergoing endocrine ablative surgery. Cancer, 19, 421

    Google Scholar 

  43. Huseby, R. A. (1958). The use of estrogen in the treatment of advanced breast cancer. Breast Cancer. The Second Biennial Louisiana Cancer Conference, p. 206. (Edited by A. Segalofl), The C. V. Mosby Company, St-Louis

    Google Scholar 

  44. Escher, G. C. Clinical improvement of inoperable breast carcinoma under steroid treatment. In Proc. of the 1st conference on steroid hormones and mammary carcinoma. April 1949, pp. 92-99. Therapeutic trials Committee, Council on Pharmac. and Chemistry of the American Medical Association

    Google Scholar 

  45. Baker, L. H. and Vaitkevicius, V. K. (1972). Reevaluation of rebound regression in disseminated carcinoma of the breast. Cancer, 29, 1268

    PubMed  CAS  Google Scholar 

  46. Kaufman, R. J. and Escher, G. C. (1961). Rebound regression in advanced mammary carcinoma. Surg. Gynecol. Obstet., 113, 635

    PubMed  CAS  Google Scholar 

  47. Stoll, B. A. (1969). Hormonal Management in Breast Cancer. Pitman Med. Publishing Cy. Ltd.

    Google Scholar 

  48. Keating, J. L., Yonemoto, R. H. and Byron, R. L. (1968). Cytotoxic drug and hormone therapy after adrenalectomy for advanced breast cancer. Surg. Gynecol. Obstet., 127, 538

    PubMed  CAS  Google Scholar 

  49. Pearson, O. H. and Ray, B. S. (1959). Results of hypophysectomy in the treatment of metastatic mammary carcinoma. Cancer, 12, 85

    PubMed  CAS  Google Scholar 

  50. Talley, R. W., Brennan, M. J., Vaitkevicius, V. K., San Diego, E. L., Reed, M. L. and Leighton, G. A. (1964). Comparison of 6a-methyl-9a-fluoro-17acetoxy-21-deoxyprednisolone with fluoxymesterone and methyl prednisolone in treatment of metastatic breast cancer. Cancer, 17, 1063

    PubMed  CAS  Google Scholar 

  51. Kim, U. (1965). Pituitary function and hormonal therapy of experimental breast cancer. Cancer Res., 25, 1146

    PubMed  CAS  Google Scholar 

  52. Lerner, L. J. and Hilf, R. (1967). Biological activities of steroids and their relationship to breast cancer therapy. Current Concepts in Breast Cancer, p. 80. ( Edited by A. Segaloff, K. K. Meyer and S. Debakey) The Williams and Wilkins Company, Baltimore

    Google Scholar 

  53. Meites, J. and Nicoll, C. S. (1966). Adenohypophysis: prolactin. Annu. Rev. Physiol., 28, 57

    PubMed  CAS  Google Scholar 

  54. Heuson, J. C. (1974). The role of prolactin inhibition in [the] treatment [of breast cancer]. Mammary Cancer and Neuroendocrine Therapy. p. 349 ( Edited by B. Stoll). Butterworth, London.

    Google Scholar 

  55. L’Hermite, M., Heuson, J. C., Rozencweig, M. and Robyn, Cl. (1974). Breast cancer regression under oestrogen therapy. Brit. Med. J., 1, 390.

    PubMed  Google Scholar 

  56. Engelsman, E., Persijn, J. P., Korsten, C. B. and Cleton, F. J. (1973). Oestrogen receptor in human breast cancer tissue and response to endocrine therapy. Brit. _Med. J., 2, 750

    PubMed  CAS  Google Scholar 

  57. Jensen, E. V., Block, G. E., Smith, S., Kyser, K. and DeSombre, E. R. (1971). Estrogen receptors and hormone dependency. Estrogen Target Tissue and.Neoplasia. (Edited by T. L. Dao). The University of Chicago Press, Chicago and London

    Google Scholar 

  58. Maass, H., Engel, B., Hohmeister, H., Lehmann, F. and Trams, G. (1972). Estrogen receptors in human breast cancer tissue. Am. J. Obstet. Gynecol., 113, 377

    PubMed  CAS  Google Scholar 

  59. Emerson, W. J., Kennedy, B. J., Graham, J. N. and Nathanson, I. T. (1953). Pathology of primary and recurrent carcinoma of the human breast after administration of steroid hormones. Cancer, 6, 641

    PubMed  CAS  Google Scholar 

  60. Hall, T. C., Dederick, M. M. and Nevinny, H. B. (1963). Prognostic value of hormonally induced hypercalcemia in breast cancer. Cancer Chemother. Rep., 30, 21

    PubMed  CAS  Google Scholar 

  61. Beckett, V. L. (1969). Hypercalcemia associated with estrogen administration in patients with breast carcinoma. Cancer, 24, 610

    PubMed  CAS  Google Scholar 

  62. Galasko, C. S. B. and Burn, I. (1971). Hypercalcemia in patients with advanced mammary cancer. Brit. Med. J., 3, 573

    PubMed  CAS  Google Scholar 

  63. Veterans Administration Co-operative Urological Research Group (1967). Treatment and survival of patients with cancer of the prostate. Surg. Gynecol. Obstet., 124, 1011

    Google Scholar 

  64. Fels, E. (1944). Treatment of breast cancer with testosterone propionate. y. Clin. Endocrinol. Metab., 4, 121

    Google Scholar 

  65. Farrow, J. H. and Woodard, H. O. (1942). The influence of androgenic and estrogenic substances on serum calcium in cases of skeletal metastases from mammary cancer. j. Amer. Med. Ass., 18, 339

    Google Scholar 

  66. Adair, F. E. and Herrmann, J. B. (1946). Use of testosterone propionate in treatment of advanced carcinoma of breast. Ann. Sur, g., 123, 1023

    Google Scholar 

  67. de Lorimier, A. A., Gordan, G. S., Lowe, R. C. and Carbone, J. V. (1965). Methyltestosterone, related steroids and liver function. Arch. Intern. Med., 116, 289

    Google Scholar 

  68. Beckett, V. L. and Brennan, M. J. (1959). Treatment of advanced breast cancer with fluoxymesterone (Halotestin). Surg. Gynecol. Obstet., 109, 235

    PubMed  CAS  Google Scholar 

  69. Segaloff, A., Weeth, J. B., Rongone, E. L., Murison, P. J. and Bowers, C. Y. (1960). Hormonal therapy in cancer of the breast. XVI. The effect of A1testololactone on clinical course and hormonal excretion. Cancer, 13, 1017

    PubMed  CAS  Google Scholar 

  70. Groupe Européen du Cancer du Sein (1962). Le traitement hormonal du cancer du sein. Rev. Eur. Etud. Clin. Biol., 7, 1067

    Google Scholar 

  71. Goldenberg, I. S., Waters, M. N., Ravdin, R. S., Ansfield, F. J. and Segaloff, A. (1973). Androgenic therapy for advanced breast cancer in women. J. Amer. Med. Ass.,223,1267

    Google Scholar 

  72. Gordan, G. S., Halden, A., Horn, Y., Fuery, J. J., Parsons, R. J. and Walter, R. M. (1973). Calusterone (713,17a-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer. Oncology, 28, 138

    PubMed  CAS  Google Scholar 

  73. Gordon, D., Horwitt, B. N., Segaloff, A., Murison, P. J. and Schlosser, J. V. (1952). Hormonal therapy in cancer of the breast. III. Effect of progesterone on clinical course and hormonal excretion. Cancer, 5, 275

    PubMed  CAS  Google Scholar 

  74. Taylor, S. G., III, and Morris, R. S., Jr. (1951). Hormones in breast metastasis therapy. Med. Clin. North. Am., 35, 51

    PubMed  Google Scholar 

  75. Crowley, L. G. and Macdonald, I. (1962). Clinical trial of Delalutin in the treatment of advanced mammary carcinoma in postmenopausal women. Cancer, 15, 1218

    PubMed  CAS  Google Scholar 

  76. Jones, V., Joslin, C. A. F., Jones, R. E., Davies, D. K. L., Roberts, M. M., Gleave, E. N., Campbell, H., Forrest, A. P. M. (1971). Progestogens and advanced breast cancer. Lancet, i, 1049

    Google Scholar 

  77. Crowley, L. G. and Macdonald, I. (1965). Delalutin and estrogens for the treatment of advanced mammary carcinoma in the postmenopausal woman. Cancer, 18, 436

    PubMed  CAS  Google Scholar 

  78. Ahmann, D. L., Hahn, R. G. and Bisel, H. F. (1972). Disseminated breast cancer: evaluation of he rmonal therapy utilizing stilboestrol and Medrogestone (Ay-62022) singly and in combination. Cancer, 30, 651

    PubMed  CAS  Google Scholar 

  79. Berndt, G. und Stender, H. St. (1970). Die Östrogen-Gestagen-Kombinationsbehandlung des metastasierenden Mammakarzinoms mit SH 834. Dtsch. Med. Wochenschr., 48, 2399

    Google Scholar 

  80. Landau, R. L., Ehrlich, E. N. and Huggins, C. (1962). Estradiol benzoate and progesterone in advanced human-breast cancer. J. Amer. Med. Ass., 182, 632

    Google Scholar 

  81. Stoll, B. A. (1967). Effect of Lyndiol, an oral contraceptive, on breast cancer. Brait. Med. J., 1, 150

    CAS  Google Scholar 

  82. Talley, R. W., O’Bryan, R. M., Burrows, J. H. and San Diego, E. L. (1970). Comparison of 41-Testololactone and an estrogen progestin combination in the treatment of metastatic breast cancer. Cancer Chemother. Rep., 54, 249

    PubMed  CAS  Google Scholar 

  83. Goldenberg, I. S. and Hayes, M. A. (1959). Hormonal therapy of metastatic female breast cancer. I. 9a-Fluoro-l1-keto-progesterone. Cancer, 12, 738

    PubMed  CAS  Google Scholar 

  84. Jonsson, U., Colsky, J., Lessner, H. E., Roath, O. S., Alper, R. G. and Jones, R., Jr. (1959). Clinical and pharmacological observations of the effects of 9-a-bromo-11-ß-ketoprogesterone in patients with carcinoma of the breast. Cancer, 12, 509

    PubMed  CAS  Google Scholar 

  85. Gorins, A. and Netter, A. (1969). L’apport des norstéroïdcs dans le traitement des cancers du sein en phase avancée. Presse Med., 77, 817

    PubMed  CAS  Google Scholar 

  86. Briggs, M. H., Caldwell, A. D. S. and Pitchford, A. G. (1967). The treatment of breast cancer by progestogens. Hosp. Med., 1, 63

    Google Scholar 

  87. Muggia, F. M., Cassileth, P. A., Ochoa, M., Flatow, F. A., Gellhorn, A. and Hyman, G. A. (1968). Treatment of breast cancer with medroxyprogesterone acetate. Ann. Intern. Med., 68, 3

    Google Scholar 

  88. Stoll, B. A. (1967). Progestin therapy of breast cancer: comparison of agents. Brit. Med. J., 3, 338

    CAS  Google Scholar 

  89. Kaufman, R. J., Rothschild, E. O., Escher, G. C. and Myers, W. P. L. (1964). Hypercalcemia in mammary carcinoma following the administration of a progestational agent. J. Clin. Endocrinol. Metab., 24, 1235

    PubMed  CAS  Google Scholar 

  90. Stoll, B. A. (1966). Therapy by progestational agents in advanced breast cancer. Med. J. Aust., 1, 331

    PubMed  CAS  Google Scholar 

  91. Volk, H., Escher, G. C., Huseby, R. A., Tyler, F. H. and Cheda, J. (1960). Hormonal therapy in carcinoma of the breast: I. Effect of oral progesterone on clinical course and metabolism of nitrogen and selected electrolytes and steroids. Cancer, 13, 757

    CAS  Google Scholar 

  92. Carter, S. K. (1972). Single and combination nonhormonal chemotherapy in breast cancer. Cancer, 30, 1543

    PubMed  CAS  Google Scholar 

  93. Segalof, A., Carabasi, R., Horwitt, B. N., Schlosser, J. V. and Murison, P. J. (1954). Hormonal therapy of cancer of the breast. VI. Effect of ACTH and cortisone on clinical course and hormonal excretion. Cancer, 7, 331

    Google Scholar 

  94. Dao, T. L., Tan, E. and Brooks, V. (1961). A comparative evaluation of adrenalectonty and cortisone in the treatment of advanced mammary carcinoma. Cancer, 14, 1259

    PubMed  CAS  Google Scholar 

  95. Van Gilse, H. A. (1962). Long-term treatment with corticosteroids of patients with metastatic breast cancer. Cancer Chemother. Rep., 16, 293

    PubMed  CAS  Google Scholar 

  96. Stoll, B. A. (1963). Corticostcroids in therapy of advanced mammary cancer. Brit. Med. J., 2, 210

    PubMed  CAS  Google Scholar 

  97. Firat, D. and Olshin, S. (1968). Treatment of metastatic carcinoma of the female breast with combinations of hormones and other chemotherapy. Cancer Chemother. Rep., 52, 743

    PubMed  CAS  Google Scholar 

  98. Kofman, S., Nagarnani, D., Buenger, R. and Taylor, S. G., III (1958). The use of prednisolone in the treatment of disseminated breast carcinoma. Cancer, 11, 226

    PubMed  CAS  Google Scholar 

  99. Lemon, H. M. (1957). Cortisone-thyroid therapy of metastatic mammary cancer. Ann. Intern. Med., 46, 457

    PubMed  CAS  Google Scholar 

  100. Lemon, H. M. (1959). Prednisone therapy of advanced mammary cancer. Cancer, 12, 93

    PubMed  CAS  Google Scholar 

  101. Gardner, B., Thomas, A. N. and Gordan, G. S. (1962). Antitumor efficacy of prednisone and sodium liothyronine in advanced breast cancer. Cancer, 15, 334

    PubMed  CAS  Google Scholar 

  102. Brinkley, D. M. and Kingsley Pillers, E. (1960). Treatment of advanced carcinoma of the breast by bilateral oophorectomy and prednisone. Lancet, i, 123

    Google Scholar 

  103. Forrest, A. P. M., Stewart, H. J., Benson, E. A., Ker, H., Jones, V., Kunkler, P. B. and Campbell, H. (1968). Controlled studies in advanced breast cancer. Prognostic Factors in Breast Cancer, p. 186. ( Edited by A. P. M. Forrest and P. B. Kunkler). Edinburgh and London: Livingstone

    Google Scholar 

  104. Nissen-Meyer, R. and Vogt, J. H. (1959). Cortisone treatment of metastatic breast cancer. Acta Unio. Int. Contra. Cancro., 15, 1140

    CAS  Google Scholar 

  105. Stoll, B. A. (1960). Dexamethasone in advanced breast cancer. Cancer, 13, 1074

    PubMed  CAS  Google Scholar 

  106. Hildebrand, J., Brihaye, J., Wagenknecht, L., Michel, J. and Kenis, Y. (1973). Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-l-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors. A preliminary report. Ear. y. Cancer, 9, 627

    CAS  Google Scholar 

  107. Grodin, J. M., Suteri, P. K. and MacDonald, P. C. (1973). Source of estrogen production in postmenopausal women. y. Clin. Endocrinol. Metab., 36, 207

    CAS  Google Scholar 

  108. Nissen-Meyer, R. and Sanner, T. (1963). The excretion of estrone, pregnanediol and pregnanetriol in breast cancer patients. Acta Endocrinol. (ICbh), 44, 334

    CAS  Google Scholar 

  109. Barlow, J. J., Emerson, K., Jr. and Saxena, B. N. (1969). Estradiol production after ovariectomy for carcinoma of the breast. New Engl. J. Med., 280, 633

    PubMed  CAS  Google Scholar 

  110. Suez, J. (1971). Adrenal function in cancer: relation to the evolution. Eur. y. Cancer, 7, 381

    Google Scholar 

  111. Suez, J. (1971). Adrenal function in cancer: relation to the evolution. Eur. y. Cancer, 7, 381

    Google Scholar 

  112. Harper, M. J. K. and Walpole, A. L. (1966). Contrasting endocrine activities of cis and trans isomers in a series of substituted triphenylethylenes..Nature, 212, 87

    CAS  Google Scholar 

  113. Terenius, L. (1970). Two modes of interaction between oestrogen and anti-oestrogen. Acta Endocrinol., 64, 47

    PubMed  CAS  Google Scholar 

  114. Jensen, E. V., DeSombre, E. R. and Jungblut, P. W. (1967). Estrogen receptors in hormone-responsive tissues and tumors. International Symposium on Endogenous Factors Influencing Host-Tumor Balance, p. 15. ( Edited by R. W. Wissler, T. L. Dao and S. Wood, Jr.). The University of Chicago Press, Chicago and London

    Google Scholar 

  115. Steggles, A. W. and King, R. J. B. (1970). The use of protamin to study 16,7-3H1oestradiol-l7ß binding in rat uterus. Biochem. y., 118, 695

    CAS  Google Scholar 

  116. Heuson, J. C., Waelbroeck, Ch., Legros, N., Gallez, Gh., Robyn, C. and L’Hermite, M. (1971/72). Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-Br-a-ergocryptine (CB 154), an inhibitor of prolactin secretion, and by Nafoxidine (U-11, 100A), an estrogen antagonist. Gynecol. Invest., 2, 130

    Google Scholar 

  117. Terenius, L. (1971). Anti-oestrogens and breast cancer. Eur. J. Cancer, 7, 57

    CAS  Google Scholar 

  118. Heuson, J. C., Engelsman, E., Blonck-Van der Wijst, D., Maas, H., Gorins, A. and Drochmans, A. (1974). Controlled trial of Nafoxidine and ethinyloestradiol in advanced breast cancer. An E.O.R.T.C. Breast Cancer Group study. In preparation

    Google Scholar 

  119. Ward, H. W. C. (1973). Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels. Brit. Med. J., 1, 13

    PubMed  CAS  Google Scholar 

  120. Pearson, O. H., Llerena, O., Llerena, L., Molina, A. and Butler, T. (1969). Prolactin-dependent rat mammary cancer: a model for man? Trans. Ass. Am. Physicians., 82, 225

    CAS  Google Scholar 

  121. Pasteels,,J. L., Danguy, A., Frérotte, M. and Ectors, F. (1971). Inhibition de la sécrétion de prolactine par l’ergocornine et la 2-Br-a-ergocryptine: action directe sur l’hypophyse en culture. Ann. Endocrinol., 32, 188

    Google Scholar 

  122. Heuson, J. C., Waelbroeck-Van Gaver, C. and Legros, N. (1970). Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-a-ergocryptine, a suppressor of lactation and nidation. Eur. J. Cancer, 6, 353

    PubMed  CAS  Google Scholar 

  123. Frantz, A. G., Habis, D. V., Hyman, G. A., Suh, H. K., Sassin, J. S., Zimmerman, E. A., Noel, G. L. and Kleinberg, D. L. (1973). Physiological and pharmacological factors affecting prolactin secretion, including its suppression by L-dopa in the treatment of breast cancer. Human Prolactin, p. 273. (Edited by J. L. Pasteels and C. Robyn). lnternatl. Congress Series, no. 308. Excerpta Medica, Amsterdam. American Elsevier Publishing Cy. Inc., New York

    Google Scholar 

  124. Engelsman, E., Heuson, J. C., Blonk-Van der Wijst, D. and Maass, H. (1974). Controlled trial of L-dopa in advanced breast cancer. An E.O.R.T.C. Breast Cancer Group study. In preparation

    Google Scholar 

  125. Rozencweig, M., Heuson, J. C., Bila, S., L’Hermite, M. and Robyn, C. (1973). Effects of 2-Br-a-ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women. Eur. j. Cancer, 9, 657

    PubMed  CAS  Google Scholar 

  126. Taylor, S. G. (1962). Endocrine ablation in disseminated mammary carcinoma. Surg. Gynecol. Obstet., 115, 443

    PubMed  Google Scholar 

  127. Hall, T. C., Dederick, M. M., Nevinny, H. B. and Muench, H. (1963). Prognostic value of response of patients with breast cancer to therapeutic castration. Cancer Chemother. Rep., 31, 47

    PubMed  CAS  Google Scholar 

  128. Dao, T. L. and Tan, E. (1962). A comparative evaluation of adrenalectomy and androgen in advanced mammary carcinoma. Cancer Chemother. Rep., 16, 309

    PubMed  CAS  Google Scholar 

  129. Kennedy, B. J. (1965). Diethylstilbestrol versus testosterone propionate therapy in advanced breast cancer. Surg. Gynecol. Obstet., 120, 1246

    PubMed  CAS  Google Scholar 

  130. Haines, C. R., Wallace, H. J., Nevinny, H. B. (1969). Clinical evaluation of estrogen-androgen combination in advanced breast cancer. Am. j. Surg., 117, 589

    PubMed  CAS  Google Scholar 

  131. Kennedy, B. J. and Brown, J. H. (1965). Combined estrogenic and androgenic hormone therapy in advanced breast cancer. Cancer, 18, 431

    PubMed  CAS  Google Scholar 

  132. Stoll, B. A. (1964). Fact and fallacy in the hormonal control of breast cancer. Med. y. Aust., 1, 980

    CAS  Google Scholar 

  133. Stoll, B. A. (1973). Hypothesis: breast cancer regression under oestrogen therapy. Brit. Med. j., 3, 446

    PubMed  CAS  Google Scholar 

  134. Huseby, R. A. (1954). Estrogen therapy in the management of advanced breast cancer. Am. Surg., 20, 112

    PubMed  CAS  Google Scholar 

  135. Duncan, G. W., Lyster, S. C., Clark, J. J. and Lednicer, D. (1963). Antifertility activities of two diphenyl-dihydronaphtalene derivatives. Proc. Soc. Exp. Biol. Med., 112, 439

    CAS  Google Scholar 

  136. Kennedy, B. J. (1965). Hormone therapy for advanced breast cancer. Cancer, 18, 1551

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. C. Heuson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Hedley Atkins K.B.E.

Rights and permissions

Reprints and permissions

Copyright information

© 1974 Professor Sir Hedley Atkins K.B.E.

About this chapter

Cite this chapter

Heuson, J.C. (1974). Hormones by administration. In: Atkins, H. (eds) The Treatment of Breast Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7152-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-7152-6_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-7154-0

  • Online ISBN: 978-94-011-7152-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation